Paradigm Shift for Parkinson’s
At Cellestial Health, our mission is to pioneer disruptive yet accessible therapies that restore and protect astrocytic networks, addressing incurable conditions such as Parkinson’s Disease.
We are committed to reducing the global burden of neurodegenerative diseases, promoting health equity, and advancing science with the potential to transform lives.
The Four Cellestial C’s
At the core of Cellestial Health, our values drive everything we do, guiding our approach to innovation, patient care, and teamwork. These principles empower us to push boundaries, remain steadfast in our mission, and work together to make a meaningful impact in the fight against neurodegenerative diseases.
Compassion
Patient-Centric Innovation: At Cellestial Health, we are driven by our commitment to improving patients’ quality of life.
Our focus extends beyond simply addressing motor symptoms in Parkinson’s, targeting both motor and non-motor complications to provide holistic solutions.
By prioritising small molecules as our therapeutic modality, we aim to deliver accessible treatments to patients worldwide, including those for whom more invasive interventions may not be suitable for health or economic reasons.
Through this approach, we strive to offer therapies that not only improve physical well-being but also enhance overall patient experiences, bringing hope to underserved communities and advancing equitable care.
Commitment
Relentless in Discovery: Drug discovery and development are complex and challenging journeys, but we are steadfast in our determination to overcome obstacles.
We embrace continuous improvement and welcome constructive feedback to fuel progress toward life-changing therapies.
Collaboration
Partnership for Progress: Collaboration is at the heart of our mission. Just as brain cells rely on networks to function, we believe in the power of partnerships to drive breakthroughs.
We actively seek and foster collaborations with academic institutions, contract research organisations (CROs), and industry partners to accelerate innovation and achieve our goals together.
Courage
Pioneering Unmet Needs: We are committed to tackling complex and currently incurable brain diseases.
Recognising the significant unmet clinical demand, we actively pursue cutting-edge therapeutic strategies that harness the strengths of our technology to redefine the possibilities of neurodegenerative treatment.
Our Commitment to Sustainable Innovation
Cellestial Health is committed to sustainable pharmaceutical practices, integrating eco-friendly materials wherever possible, minimising waste, and adopting remote work to reduce our carbon footprint. We carefully assess the inclusivity and diversity practices of potential partners to ensure alignment with our values.
Furthermore, we adhere to the 3R principles; replacement, reduction and refinement, in our preclinical research. Our goal is to reduce our environmental impact while continuing to deliver life-saving therapies.